Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats

Neuroscience Letters

Volumn 479, Issue 1, 2010, Pages 26-30

  Xie, Jun ^a   Jiang, Libin ^a   Zhang, Ting ^a   Jin, Yulan ^a   Yang, Dongmei ^a   Chen, Fei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Epigallocatechin 3 gallate (EGCG); Neuroprotection; Optic nerve crush (ONC); Retinal ganglion cells (RGCs)

Indexed keywords

ACTIN; EPIGALLOCATECHIN GALLATE; FLUOROGOLD; NEUROFILAMENT L PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG; CATECHIN; NEUROFILAMENT PROTEIN L; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOW DRUG DOSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; SURVIVAL RATE; TISSUE LEVEL; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL COUNT; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CRUSH; OPTIC NERVE INJURIES; PATHOLOGY; RANDOMIZATION; RETINA; TIME; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; CATECHIN; CELL COUNT; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; NERVE CRUSH; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; OPTIC NERVE INJURIES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RETINA; RETINAL GANGLION CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953720395     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.020     Document Type: Article

References (15)

1. Costa B.L.d.S.A.d., Fawcett R., Li G.-Y., Safa R., Osborne N.N. Orally administered epigallocatechin gallate attenuates light-induced photoreceptor damage. Brain Res. Bull. 2008, 76:412-423.
2. Faden A. Pharmacological treatment of central nervous system trauma. Pharmacol. Toxicol. 1996, 18:12-17.
3. Fitzgerald M., Bartlett C.A., Evill L., Rodger J., Harvey A.R., Dunlop S.A. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Exp. Neurol. 2009, 216:219-230.
4. Johnson T.V., Tomarev S.I. Rodent models of glaucoma. Brain Res. Bull. 2010, 81:349-358.
5. Lee M.K., Cleveland D.W. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 1994, 6:34-40.
6. Lee S., Suh S., Kim S. Protective effects of the green tea (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci. Lett. 2000, 28:191-194.
7. Levkovitch-Verbin H., Dardik R., Vander S., Melamed S. Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Exp. Eye Res. 2009, (available online 29.11.09).
8. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Zack D.J., Pease M.E., Valenta D.F. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transaction. Invest. Ophthalmol. Vis. Sci. 2003, 44:3388-3393.
9. Peng P., Ko M., Chen C. Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity. Exp. Eye Res. 2008, 86:637-646.
10. Smith D.H., Casey K., McIntosh T.K. Pharmacologic therapy for traumatic brain injury: experimental approaches. New Horiz. 1995, 3:562-572.
11. Srividhya R., Jyothilakshmi V., Arulmathi K., Senthilkumaran V., Kalaiselvi P. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate. Int. J. Dev. Neurosci. 2008, 26:217-223.
12. Sutherland B.A., Rahman R.M.A., Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem. 2006, 17:291-306.
13. Yoles E, Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 1998, 153:1-7.
14. Zhang B., Rusciano D., Osborne N.N. Orally administered epigallocatechin gallate attenuates retina neuronal death in vivo and light-induced apoptosis in vitro. Brain Res. 2008, 1198:141-152.
15. Zhang B., Safa R., Rusciano D., Osborne N.N. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res. 2007, 1159:40-53.